Ani Pharmaceuticals (ANIP) Enterprise Value (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Enterprise Value of -$311.2 million for Q1 2026, down 8.96% sequentially from -$285.6 million in Q4 2025, and down 107.7% YoY from $4.0 billion in Q1 2025.
Ani Pharmaceuticals (ANIP) Enterprise Value (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Enterprise Value for 17 years, with the latest figure at -$311.2 million in Q1 2026.
- Quarterly Enterprise Value fell 107.7% year-over-year to -$311.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$311.2 million (down 107.7% YoY) and the FY2025 annual result came in at -$285.6 million, down 97.12% from the prior year.
- Enterprise Value slipped to -$311.2 million in Q1 2026 per ANIP's latest filing, from -$285.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$53.2 million in Q4 2022 and troughed at -$311.2 million in Q1 2026.
- A 5-year average of -$170.2 million and a median of -$161.7 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 49.45% in 2022, then plunged 315.38% in 2023.
- Over 5 years, Enterprise Value stood at -$53.2 million in 2022, then slumped by 315.38% to -$221.1 million in 2023, then soared by 34.47% to -$144.9 million in 2024, then plunged by 97.12% to -$285.6 million in 2025, then fell by 8.96% to -$311.2 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$311.2 million, -$285.6 million, and -$262.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Ani Pharmaceuticals | 1.64 Bn | 1.28 Bn | 165.89 Mn | -360.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -360.25 Mn |
| Mar 31, 2026 | -311.21 Mn |
| Dec 31, 2025 | -285.62 Mn |
| Sep 30, 2025 | -262.65 Mn |
| Jun 30, 2025 | -217.83 Mn |
| Mar 31, 2025 | -149.84 Mn |
| Dec 31, 2024 | -144.89 Mn |
| Sep 30, 2024 | -145.02 Mn |
| Jun 30, 2024 | -240.11 Mn |
| Mar 31, 2024 | -228.60 Mn |
| Dec 31, 2023 | -221.12 Mn |
| Sep 30, 2023 | -193.08 Mn |
| Jun 30, 2023 | -161.71 Mn |
| Mar 31, 2023 | -67.76 Mn |
| Dec 31, 2022 | -53.23 Mn |
| Sep 30, 2022 | -61.28 Mn |
| Jun 30, 2022 | -68.39 Mn |
| Mar 31, 2022 | -81.91 Mn |
| Dec 31, 2021 | -105.30 Mn |
| Sep 30, 2021 | -15.25 Mn |